NO822837L - Fremgangsmaate for fremstilling av et legemiddel. - Google Patents
Fremgangsmaate for fremstilling av et legemiddel.Info
- Publication number
- NO822837L NO822837L NO822837A NO822837A NO822837L NO 822837 L NO822837 L NO 822837L NO 822837 A NO822837 A NO 822837A NO 822837 A NO822837 A NO 822837A NO 822837 L NO822837 L NO 822837L
- Authority
- NO
- Norway
- Prior art keywords
- emulsion
- oil
- water
- drug
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000000839 emulsion Substances 0.000 claims description 61
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 43
- 239000003921 oil Substances 0.000 claims description 42
- 235000019198 oils Nutrition 0.000 claims description 42
- 229940079593 drug Drugs 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 26
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims description 22
- 229940108325 retinyl palmitate Drugs 0.000 claims description 22
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 22
- 239000011769 retinyl palmitate Substances 0.000 claims description 22
- 239000004094 surface-active agent Substances 0.000 claims description 19
- 244000215068 Acacia senegal Species 0.000 claims description 11
- 229920000084 Gum arabic Polymers 0.000 claims description 11
- 235000010489 acacia gum Nutrition 0.000 claims description 11
- 239000000205 acacia gum Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 229920002307 Dextran Polymers 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 244000043261 Hevea brasiliensis Species 0.000 claims description 3
- 239000007903 gelatin capsule Substances 0.000 claims description 3
- 229920003052 natural elastomer Polymers 0.000 claims description 3
- 229920001194 natural rubber Polymers 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000007762 w/o emulsion Substances 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000002352 surface water Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 description 19
- 239000002775 capsule Substances 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 10
- 239000011324 bead Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000004570 mortar (masonry) Substances 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 239000003613 bile acid Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000004347 intestinal mucosa Anatomy 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 239000008159 sesame oil Substances 0.000 description 4
- 235000011803 sesame oil Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000005426 pharmaceutical component Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241000207961 Sesamum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229940119224 salmon oil Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29490781A | 1981-08-21 | 1981-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822837L true NO822837L (no) | 1983-02-22 |
Family
ID=23135451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822837A NO822837L (no) | 1981-08-21 | 1982-08-20 | Fremgangsmaate for fremstilling av et legemiddel. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0073006B1 (ko) |
| JP (1) | JPS5839619A (ko) |
| KR (1) | KR840000900A (ko) |
| AR (1) | AR231074A1 (ko) |
| AT (1) | ATE21212T1 (ko) |
| AU (1) | AU557671B2 (ko) |
| CA (1) | CA1200492A (ko) |
| DE (1) | DE3272452D1 (ko) |
| DK (1) | DK373982A (ko) |
| ES (1) | ES8500741A1 (ko) |
| NO (1) | NO822837L (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0212875A3 (en) * | 1985-08-12 | 1988-06-15 | William Gough Tucker | Medicinal composition and method of making same |
| KR100560068B1 (ko) * | 2002-03-14 | 2006-03-13 | 주식회사 태평양 | 구강용 마이크로 캡슐의 제조방법 및 이 방법에 의해 제조된 마이크로 캡슐을 함유하는 구강용 조성물 |
| JP2005119986A (ja) * | 2003-10-15 | 2005-05-12 | Japan Science & Technology Agency | 生理活性物質の投与方法、生理活性物質含有乳化液、及び生理活性物質含有乳化液の製造方法 |
| FR3026012B1 (fr) | 2014-09-23 | 2017-12-01 | Soc D'exploitation De Produits Pour Les Industries Chimiques Seppic | Administration par voie orale d'au moins une substance active pharmaceutique et/ou antigenique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1167794B (de) * | 1953-09-03 | 1964-04-16 | Corn Products Company Eine Ges | Verfahren zum Einbetten wasserunloeslicher Vitamine und anderer bei der Aufbewahrung sich verschlechternder oder verdampfender Stoffe in eine Umhuellung |
| DE973095C (de) * | 1955-01-19 | 1959-12-03 | Kalle & Co Ag | Verfahren zur UEberfuehrung von OElen in streufaehige Pulver durch Spruehtrocknung von OEl-in-Wasser-Emulsionen |
| GB919193A (en) * | 1958-11-12 | 1963-02-20 | Shinshiro Ohtaki | A method for producing powder containing oil or fat |
| US3351531A (en) * | 1965-08-09 | 1967-11-07 | Beatrice Foods Co | Wheat gluten-encapsulated dried oilin-water dispersions of fat-soluble food, medicaments, flavoring agents or food coloring agents |
-
1982
- 1982-08-11 AU AU87067/82A patent/AU557671B2/en not_active Ceased
- 1982-08-17 DE DE8282107498T patent/DE3272452D1/de not_active Expired
- 1982-08-17 AT AT82107498T patent/ATE21212T1/de not_active IP Right Cessation
- 1982-08-17 EP EP82107498A patent/EP0073006B1/en not_active Expired
- 1982-08-19 CA CA000409773A patent/CA1200492A/en not_active Expired
- 1982-08-20 AR AR290377A patent/AR231074A1/es active
- 1982-08-20 KR KR1019820003743A patent/KR840000900A/ko unknown
- 1982-08-20 NO NO822837A patent/NO822837L/no unknown
- 1982-08-20 ES ES516399A patent/ES8500741A1/es not_active Expired
- 1982-08-20 JP JP57143506A patent/JPS5839619A/ja active Pending
- 1982-08-20 DK DK373982A patent/DK373982A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3272452D1 (en) | 1986-09-11 |
| CA1200492A (en) | 1986-02-11 |
| EP0073006B1 (en) | 1986-08-06 |
| AR231074A1 (es) | 1984-09-28 |
| AU8706782A (en) | 1983-05-12 |
| KR840000900A (ko) | 1984-03-26 |
| EP0073006A2 (en) | 1983-03-02 |
| EP0073006A3 (en) | 1983-08-24 |
| ES516399A0 (es) | 1984-11-01 |
| JPS5839619A (ja) | 1983-03-08 |
| ES8500741A1 (es) | 1984-11-01 |
| ATE21212T1 (de) | 1986-08-15 |
| AU557671B2 (en) | 1987-01-08 |
| DK373982A (da) | 1983-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950014440B1 (ko) | 마이크로캡슐을 포함하는 제약학적 배합물 | |
| US4963526A (en) | Oral insulin and a method of making the same | |
| ES2592504T3 (es) | Preparaciones de liberación controlada | |
| US5965160A (en) | Self-emulsifiable formulation producing an oil-in-water emulsion | |
| US4857335A (en) | Liquid controlled release formulations and method of producing same via multiple emulsion process | |
| EP0102265A2 (en) | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents | |
| NL8802657A (nl) | Geneesmiddeldragers. | |
| CN102448441B (zh) | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 | |
| CN109922811A (zh) | 包含至少一种氧化胆固醇硫酸酯以及聚亚烷基二醇、羧甲基纤维素和聚氧乙烯甘油酯中的至少一种的组合物及其使用方法 | |
| CN102697724A (zh) | 氯吡格雷及其盐亚微乳注射液及其制备方法 | |
| CN102349944B (zh) | 一种黄芩提取物鼻用温敏型原位凝胶及其制备方法和用途 | |
| CN1985851B (zh) | 含有蟾酥提取物的脂质微球注射液及其制备方法 | |
| JPH0354926B2 (ko) | ||
| JPH0115A (ja) | 吸収改善製剤 | |
| CN105287406B (zh) | 一种丙泊酚脂质体冻干制剂及其制备方法 | |
| NO822837L (no) | Fremgangsmaate for fremstilling av et legemiddel. | |
| JP2007504256A (ja) | 生物活性剤の送達のための組成物及び方法 | |
| RU2353350C2 (ru) | Усовершенствованная система доставки лекарств | |
| JPH06219942A (ja) | トラネキサム酸配合ゼラチンカプセル製剤 | |
| CN102552145A (zh) | 一种人工脂质体的制备方法 | |
| Bates et al. | Gastrointestinal absorption of griseofulvin from corn oil-in-water emulsions: effect of amount of corn oil ingested in man | |
| EP0896819A1 (en) | Antiglucocorticoid drug | |
| CN105796497A (zh) | 一种高贮藏稳定性薏苡仁油温敏脂质体的制备方法 | |
| NO178175B (no) | Fremgangsmåte til fremstilling av en mykgelatinkapsel | |
| JPS63246333A (ja) | 抗パントテン酸欠亡成分を主剤とする腸管活性型ソフトカプセル製剤 |